These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8409050)

  • 1. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of class Ia/Ib versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associated with coronary artery disease.
    Khalighi K; Peters RW; Feliciano Z; Shorofsky SR; Gold MR
    Am J Cardiol; 1997 Sep; 80(5):591-4. PubMed ID: 9294987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and determinants of multiple morphologically distinct sustained ventricular tachycardias.
    Wilber DJ; Davis MJ; Rosenbaum M; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Sep; 10(3):583-91. PubMed ID: 3624665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive prediction of efficacy of type IA antiarrhythmic drugs by the signal-averaged electrocardiogram in patients with coronary artery disease and sustained ventricular tachycardia.
    Hopson JR; Kienzle MG; Aschoff AM; Shirkey DR
    Am J Cardiol; 1993 Aug; 72(3):288-93. PubMed ID: 8342506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies.
    Horwich T; Lee SJ; Saxon L
    Am J Cardiol; 2003 Oct; 92(7):804-9. PubMed ID: 14516880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
    Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
    Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects of antiarrhythmic drug therapy in the prediction of successful suppression of induced ventricular tachycardia.
    Karagounis LA; Anderson JL; Allen A; Osborn JS
    Am Heart J; 1995 Feb; 129(2):343-9. PubMed ID: 7832108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determining factors of acceleration in sustained monomorphic ventricular tachycardias in response to bursts of stimuli].
    San Román Sánchez D; Almendral Garrote J; Arenal Maíz A; Delcán Domínguez JL
    Rev Esp Cardiol; 1992; 45(7):438-46. PubMed ID: 1439068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation mapping in patients with coronary artery disease with multiple ventricular tachycardia configurations: occurrence and therapeutic implications of widely separate apparent sites of origin.
    Waspe LE; Brodman R; Kim SG; Matos JA; Johnston DR; Scavin GM; Fisher JD
    J Am Coll Cardiol; 1985 May; 5(5):1075-86. PubMed ID: 3989117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
    Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA; DeCaro M; Hessen S
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1445-53. PubMed ID: 1383955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous sustained ventricular tachycardia in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Anderson KP; Walker R; Dustman T; Fuller M; Mori M
    J Am Coll Cardiol; 1995 Aug; 26(2):489-96. PubMed ID: 7541813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.